1. Indications and Usage
Antispasmodic: Relief of smooth muscle spasms in the gastrointestinal, biliary, and urinary tracts (e.g., acute abdominal pain, renal colic).
Circulatory Support: Treatment of septic shock and other types of shock with microcirculatory disorders.
Vertigo: Management of vertigo caused by cerebrovascular or inner ear diseases.
2. Dosage and Administration
Adults: The usual dosage is 5 mg to 20 mg per dose, taken 3 to 4 times daily.
Children: The dosage for children should be determined by a physician based on age and body weight.
Administration: Oral administration.
3. Mechanism of Action
Muscarinic Receptor Antagonism: Anisodamine hydrobromide competitively blocks muscarinic cholinergic receptors, inhibiting parasympathetic nerve impulses to relax visceral smooth muscles.
Microcirculation: It relaxes blood vessel spasms, improves microcirculation, and reduces vascular resistance, which is critical for its role in shock management.
4. Safety and Warnings
Contraindications: Contraindicated in patients with glaucoma, prostatic hyperplasia, intestinal obstruction, or severe cardiac conditions.
Special Populations: Use with caution in the elderly. Not recommended for women during pregnancy or breastfeeding unless absolutely necessary.
Monitoring: During shock treatment, close monitoring of vital signs and urine output is essential.
5. Adverse Reactions and Clinical Research
Common Effects: Dry mouth, flushing, blurred vision, tachycardia, and dizziness.
Severe Effects: In cases of overdose or hypersensitivity, delirium, hallucinations, and severe urinary retention may occur.
6. Drug Interactions
Additive Anticholinergic Effects: Concomitant use with other anticholinergic drugs (e.g., atropine, tricyclic antidepressants, antihistamines) may potentiate adverse effects like dry mouth and urinary retention.
Absorption: Drugs that slow gastric emptying may alter the absorption rate of anisodamine.
7. Pharmaceutical Information
Active Ingredient: Anisodamine Hydrobromide.
Strength: Tablets typically contain 5 mg of anisodamine hydrobromide.

Chengyi Anisodamine Hydrobromide Tablets
Brand Name: 成一®(Chengyi®)
Generic Name: Anisodamine Hydrobromide
Strength: 5 mg per tablet
Manufacturer: Chengdu First Pharmaceutical Co., Ltd.
Marketing Authorization Holder: Chengdu First Pharmaceutical Co., Ltd.
Approval Date in China: 2003‑04‑16
Registration Number: National Medicine Approval No. H51023899
Storage: Store in tightly‑closed container, protected from light
Price&Cost:Contact Us now for the best price of Anisodamine Hydrobromide(Chengyi)
Only logged in customers who have purchased this product may leave a review.





Reviews
There are no reviews yet.